Novartis Venture Fund
William Connors is a skilled research scientist currently employed at Novartis Institutes for BioMedical Research (NIBR) since February 2022, where responsibilities include advanced research in the field of biomedical sciences. Prior experience includes serving as a Research Scientist I and Graduate Associate at AstraZeneca from September 2019 to July 2021, where William Connors participated in multiple rotations focused on the design and synthesis of anti-cancer agents, chemical probe synthesis, and the development of novel chemical methodologies. William Connors also worked as a Medicinal Chemistry Intern at AstraZeneca in the summer of 2018, synthesizing compounds for biochemical assays. Academic credentials include a Bachelor of Arts in Chemistry from the College of the Holy Cross, earned in 2019.
This person is not in any teams
This person is not in any offices
Novartis Venture Fund
3 followers
Novartis Venture Fund's primary focus is on the development of novel therapeutics and platforms. In their investments, they look for unmet need and clinical impact, novel proprietary science, and understanding of the mechanism, management, and board experience and capital efficiency in the program.